The company’s facilities were designed and constructed in accordance with international cGMP standards. Chengdu Shuode Pharmaceutical Co., Ltd. integrates pharmaceutical manufacturing with information technology to achieve digital and intelligent management throughout the drug production process. The company has established eight modern pharmaceutical production lines covering various dosage forms, including tablets, capsules, small-volume injections, pre-filled syringes, nasal sprays, and other formulations.

To date, the company has successfully achieved the industrialization of exclusive or first generic medicines, including Norepinephrine Bitartrate Injection, Ibuprofen Injection, Bisoprolol Amlodipine Tablets, and other products. The company’s pharmaceutical manufacturing quality system has passed US FDA inspection. Products such as Nalmefene Hydrochloride Injection, Nicardipine Hydrochloride Injection, and Methylene Blue Injection have been approved for marketing in the United States.